Wouter Koudstaal

Janssen Prevention Center

Janssen Pharmaceutical Companies of Johnson and Johnson

BIOGRAPHY

Wouter Koudstaal has not added Biography.

If you are Wouter Koudstaal and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine.

Virology journal Dec, 2015 | Pubmed ID: 26643820

Immunological memory to hyperphosphorylated tau in asymptomatic individuals.

Acta neuropathologica 05, 2017 | Pubmed ID: 28341999

A common antigenic motif recognized by naturally occurring human V5-51/V4-1 anti-tau antibodies with distinct functionalities.

Acta neuropathologica communications May, 2018 | Pubmed ID: 29855358

Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser containing epitope on pathological tau.

Acta neuropathologica communications Jul, 2018 | Pubmed ID: 30001207

INSTITUTIONS

Janssen Pharmaceutical Companies of Johnson and Johnson

Janssen Pharmaceutical Company of Johnson & Johnson, The Netherlands

JOVE ARTICLES

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Rosa Crespo¹,

Wouter Koudstaal¹,

Adrian Apetri¹

¹Janssen Prevention Center, Janssen Pharmaceutical Companies of Johnson and Johnson

Neuroscience

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Donata De Marco¹,

Renske Taggenbrock^2,3,

Rosa Crespo³,

Wouter Koudstaal³,

Elizabeth Ramsburg⁴,

Adrian Apetri³

¹Neuroscience Discovery, Janssen Pharmaceutical Company of Johnson & Johnson, Belgium,

²Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, The Netherlands,

³Janssen Prevention Center, Janssen Pharmaceutical Company of Johnson & Johnson, The Netherlands,

⁴Neuroscience Discovery, Janssen Pharmaceutical Company of Johnson & Johnson, Pennsylvania

Neuroscience

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Stuart T. Perry¹,

Elissa Keogh¹,

Mike Morton¹,

Wouter Koudstaal²,

Gabriel Pascual¹

¹World Without Disease Accelerator, Janssen Pharmaceutical Companies of Johnson and Johnson,

²Janssen Prevention Center, Janssen Pharmaceutical Companies of Johnson and Johnson

Immunology and Infection

政策

使用条款

隐私

联系我们

向图书馆推荐

JoVE 新闻简报

科研

JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
Faculty Site

发表

概述
发表流程
编辑部
范围和政策
同行评审
常见问题
提交稿件

图书馆员

概述
客户评价
订阅
访问权限
资源
图书馆咨询委员会
常见问题

关于 JoVE

概述
管理层
博客
JoVE Help Center

Wouter Koudstaal

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Janssen Prevention Center

Janssen Pharmaceutical Companies of Johnson and Johnson

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Janssen Prevention Center